Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Organovo Holdings Inc (NYSE MKT LLC:ONVO)

2.54
Delayed Data
As of Aug 28
 +0.04 / +1.60%
Today’s Change
1.90
Today|||52-Week Range
7.99
-64.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$234.8M

Company Description

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.

Contact Information

Organovo Holdings, Inc.
6275 Nancy Ridge Drive
San Diego California 92121
P:(858) 224-1000
Investor Relations:
(858) 224-1003

Employees

Shareholders

Individual stakeholders18.06%
Mutual fund holders15.05%
Other institutional13.42%

Top Executives

Keith MurphyChairman, President & Chief Executive Officer
Barry D. MichaelsCFO, Co-Secretary & Head-Investor Relations
Sharon Collins PresnellCTO, Executive VP-Research & Development
Jennifer Kinsbruner BushCo-Secretary, General Counsel & Compliance Officer
Eric Michael DavidChief Strategy Officer